Hide

FocusBar

Subscribe to Premium Member
Switch to:
Insider Position Date Buy/Sell Shares Shares Owned Following This Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Dornemann MichaelDirector2013-05-14Sell73,45643,273$17.51285.5-8.46Link
Slatoff KarlCOO2013-04-15Sell22,4702,794,750$15.14340.25.81Link
Slatoff KarlCOO2013-04-02Sell136,9342,817,220$15.582133.42.82Link
ZELNICK STRAUSSChairman, CEO
(Click for the stocks that their CEOs have bought)
2013-04-02Sell136,9343,046,875$15.582133.42.82Link
KRAUSS SETH DExec VP and General Counsel2013-04-01Sell18,033585,481$15.89286.50.82Link
Goldstein LainieCFO2013-04-02Sell2,860699,439$15.9645.60.38Link
Nelson James LarryDirector2013-04-01Sell34039,982$165.40.13Link
Goldstein LainieCFO2013-03-18Sell17,815702,299$15.382744.16Link
Sheresky MichaelDirector2013-03-08Sell54761,583$15.498.53.42Link
CHO SUNGHWANDirector2013-02-19Sell61536,240$15.079.36.3Link
KRAUSS SETH DExec VP and General Counsel2013-02-19Sell7,832603,514$15.1118.36.09Link
Goldstein LainieCFO2013-02-19Sell3,470720,114$15.152.46.09Link
Sheresky MichaelDirector2013-02-19Sell61662,130$15.069.36.37Link
Nelson James LarryDirector2013-02-19Sell61540,322$15.069.36.37Link
Sheresky MichaelDirector2013-02-11Sell34659,745$15.065.26.37Link
Sheresky MichaelDirector2012-12-31Sell1,01060,091$11.0111.145.5Link
KRAUSS SETH DExec VP and General Counsel2012-12-31Sell18,174611,346$10.85197.247.65Link
Goldstein LainieCFO2012-12-31Sell13,735723,584$10.83148.847.92Link
Goldstein LainieCFO2012-12-14Sell30,000737,319$1339023.23Link
Nelson James LarryDirector2012-11-16Sell36037,936$11.724.236.69Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.


GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK